HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Mertens Selected Research

Synthetic Vaccines (Recombinant Vaccines)

1/2018The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Mertens Research Topics

Disease

4Infections
06/2014 - 06/2010
3Vaccinia
01/2018 - 06/2009
3Bluetongue
01/2013 - 06/2010
2Osteoarthritis
11/2022 - 06/2020
2Virus Diseases (Viral Diseases)
05/2012 - 04/2011
1Congenital Abnormalities (Deformity)
02/2023
1Pain (Aches)
11/2022
1Osteolysis
06/2020
1Ankle Injuries (Ankle Injury)
03/2020
1African Horse Sickness (African Horsesickness)
06/2014
1Communicable Diseases (Infectious Diseases)
01/2013
1Viremia
04/2011
1Hernia (Hernias)
09/2006
1Inguinal Hernia (Direct Inguinal Hernia)
09/2006
1Pulmonary Hypertension
05/2002
1Heterotaxy Syndrome
05/2002
1Dyspnea (Shortness of Breath)
05/2002
1Persistent Left Superior Vena Cava
05/2002

Drug/Important Bio-Agent (IBA)

3AntigensIBA
01/2018 - 06/2009
3VaccinesIBA
06/2014 - 06/2009
2Proteins (Proteins, Gene)FDA Link
01/2018 - 06/2014
2Double-Stranded RNA (RNA, Double Stranded)IBA
01/2013 - 05/2012
1Synthetic Vaccines (Recombinant Vaccines)IBA
01/2018
1Capsid Proteins (Capsid Protein)IBA
06/2014
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
06/2014
1AntibodiesIBA
06/2014
1Interferon-betaIBA
05/2012
1DNA (Deoxyribonucleic Acid)IBA
05/2012
1Interferon Receptors (Interferon Receptor)IBA
04/2011
1Heterophile AntigensIBA
04/2011
1Neutralizing AntibodiesIBA
04/2011
1Dynamins (Dynamin)IBA
06/2010
1N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA
06/2010
1AcidsIBA
06/2010
1CholesterolIBA
06/2010
1ClathrinIBA
06/2010
1Dextrans (Dextran)FDA Link
06/2010
1LipidsIBA
06/2010
1Cytochalasin DIBA
06/2010
1ethylisopropylamiloride (EIPA)IBA
06/2010
1Dynamin IIIBA
06/2010
1CollagenIBA
09/2006

Therapy/Procedure

1Osteotomy
02/2023
1Knee Replacement Arthroplasty (Total Knee Replacement)
11/2022
1Arthroplasty
06/2020
1Conservative Treatment
03/2020
1Herniorrhaphy
09/2006
1Surgical Portasystemic Shunt (Portosystemic Shunt)
05/2002